Anaplastic Large Cell Lymphoma Alk-negative
📧 Sign up to get email alerts when something new happens for Anaplastic Large Cell Lymphoma Alk-negative.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: Aclarubicin Plus Cyclophosphamide, Vincristine, and Prednisone (CAOP) in Patients With Previously Untreated Peripheral T-Cell Lymphoma [Phase 2]
Phase 2 trial evaluating CAOP (Aclarubicin, Cyclophosphamide, Vincristine, Prednisone) for previously untreated peripheral T-cell lymphoma. …
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Constitutive IL7R (C7R) Modified Banked Allogeneic CD30.CAR EBVSTS for CD30-Positive Lymphomas [Phase 1]
Phase 1 clinical trial update for constitutive IL7R (C7R) modified banked allogeneic CD30.CAR EBVSTs in CD30-positive lymphomas, currently r…
-
CLINICAL_TRIALS research · 2024-12-09Clinical Trial Update: Testing Whether High Dose Chemotherapy and Infusion of the Patients' Own Stem Cells Improves Survival in Patients With Peripheral T-cell Lymphoma Who Achieved a Complete Response at the End of the Initial Chemotherapy [Phase 3]
Phase 3 trial to evaluate whether high-dose chemotherapy followed by autologous stem cell transplantation improves survival in peripheral T-…
-
CLINICAL_TRIALS research · 2018-03-15Clinical Trial Update: CHOP vs GEM-P in 1st Line Treatment of T-cell Lymphoma, Multicentre Phase II Study [Phase 2]
Multicentre Phase II trial comparing CHOP versus GEM-P as first-line therapy for various peripheral T-cell lymphomas; current study status i…
-
CLINICAL_TRIALS research · 2017-11-14Clinical Trial Update: CTOP/ITE/MTX Compared With CHOP as the First-line Therapy for Newly Diagnosed Young Patients With T Cell Lymphoma [Phase 4]
A Phase 4 clinical trial compares the CTOP/ITE/MTX regimen against CHOP as first-line therapy for newly diagnosed young patients with variou…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.